Truffle at a Glance

_otr8838.jpg

For more than two decades, Truffle Capital has been a leading independent European VC, at the forefront of financing and nurturing innovation, playing a pivotal role in the growth and empowerment of technology leaders in two fields of expertise: Life Sciences (MedTech, Biotech & BioEcoTech) and Deeptech applied to Finance (Fintech & Insurtech).

Truffle Capital's mission is to drive the creation and development of companies on their journey to becoming tomorrow's leaders in healthcare and Finance/Insurance. Led by its two co-founders and CEOs, Dr. Philippe Pouletty and Bernard-Louis Roques, Truffle Capital has €500M AuM, raising more than €1.2 Bn since its creation and supporting more than 120 companies with numerous successful exits. In line with its DNA, Truffle acts as a lead investor in financing rounds and is proactive in terms of governance.

Our Key Figures

2001

Creation of Truffle Capital

€ 1.2Bn

Raised

€ 500M

AUM

124

Investments

45

Exits

15

IPOs

ESG

ESG is at the center of Truffle Capital's DNA and investment strategy